Evidence map›Paper›PMID 37841999›Full record

Trial reportFrontiers in cellular and infection microbiology2023

An insight into the functional alterations in the gut microbiome of healthy adults in response to a multi-strain probiotic intake: a single arm open label trial.

Andrea Rodenes-Gavidia, Araceli Lamelas, Sarah Bloor, Anthony Hobson, Sam Treadway, Jordan Haworth, Vineetha Vijayakumar, Malwina Naghibi, Richard Day, Empar Chenoll

Abstract readClinical Trial
In one paragraph

Trial report in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Effect of AG1Frontiers in nutrition · 2026
    Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrea Rodenes-GavidiaADM BIOPOLIS, University of Valencia Science Park (Parc Científic de la Universitat de València), Valencia, Spain.
Araceli LamelasADM BIOPOLIS, University of Valencia Science Park (Parc Científic de la Universitat de València), Valencia, Spain.
Sarah BloorFunctional Gut Clinic, Manchester, United Kingdom.
Anthony HobsonFunctional Gut Clinic, Manchester, United Kingdom.
Sam TreadwayFunctional Gut Clinic, Manchester, United Kingdom.
Jordan HaworthFunctional Gut Clinic, Manchester, United Kingdom.
Vineetha VijayakumarMedical Department, ADM Health & Wellness, Somerset, United Kingdom.
Malwina NaghibiMedical Department, ADM Health & Wellness, Somerset, United Kingdom.
Richard DayMedical Department, ADM Health & Wellness, Somerset, United Kingdom.
Empar ChenollADM BIOPOLIS, University of Valencia Science Park (Parc Científic de la Universitat de València), Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Probiotic supplements, by definition, provide a benefit to the host, but few studies have investigated the effect of probiotic supplements in healthy adult populations. Purpose: The present, single arm, open label clinical trial, evaluated compositional and functional changes in the fecal microbiome of healthy adults after supplementation with a 14-strain probiotic. Methods: We analysed the effect of a 14-strain probiotic blend ( Results: In healthy adult participants, no significant changes to the overall alpha- or beta-diversity was observed after 8 weeks of multi-strain probiotic supplementation. However, in a simplified model that considered only time and individual differences, significant decreases (p < 0.05) in family Conclusion: In healthy young adults, overall alpha- and beta-diversity did not change in response to probiotic intake even though modest compositional changes at the family and genus level were observed. However, at functional level, results identified changes in gene abundance for several functional pathways.

Indexed as

Gastrointestinal MicrobiomeLacticaseibacillus rhamnosusProbioticsDietary SupplementsFecesHumansYoung Adultgut microbiomehealthy adultsmetagenomicsmicrobiomeprobiotics

Identifiers

PMID37841999
PMCPMC10570534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.